MoonLake Immunotherapeutics
NASDAQ:MLTX
50.67 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Operating Activities: | ||||
| Net Income
| -36.007 | -64.506 | -53.644 | -0.091 |
| Depreciation & Amortization
| 0.013 | 0.012 | 0.005 | 0 |
| Deferred Income Tax
| -7.972 | 0 | 1.4 | 0 |
| Stock Based Compensation
| 7.106 | 0.01 | 0.011 | 0 |
| Change In Working Capital
| -6.218 | -1.427 | 4.484 | -0.216 |
| Accounts Receivables
| -0.84 | -0.068 | -0.149 | 0 |
| Inventory
| 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | -1.314 | 1.569 | 0 |
| Other Working Capital
| -5.378 | -0.045 | 3.064 | -0.216 |
| Other Non Cash Items
| 0.3 | 0.372 | 12.569 | -0.01 |
| Operating Cash Flow
| -42.778 | -55.894 | -35.175 | -0.317 |
| Investing Activities: | ||||
| Investments In Property Plant And Equipment
| -0.285 | -0.016 | -0.051 | 0 |
| Acquisitions Net
| 0.025 | 0.032 | 0 | 0 |
| Purchases Of Investments
| -175.733 | -42.226 | 0 | -115 |
| Sales Maturities Of Investments
| 150.833 | 9.901 | 0 | 0 |
| Other Investing Activites
| -0.025 | -0.032 | 0 | 0 |
| Investing Cash Flow
| -25.184 | -32.341 | -0.051 | -115 |
| Financing Activities: | ||||
| Debt Repayment
| 0 | -15 | -15 | 0 |
| Common Stock Issued
| 482.454 | 0.004 | 28.269 | 117 |
| Common Stock Repurchased
| 0 | 0 | -0.006 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 |
| Other Financing Activities
| -2.753 | 134.689 | 0.052 | -0.347 |
| Financing Cash Flow
| 479.702 | 119.693 | 43.263 | 116.653 |
| Other Information: | ||||
| Effect Of Forex Changes On Cash
| -0.075 | 0.009 | 0 | 0 |
| Net Change In Cash
| 411.664 | 31.467 | 6.703 | 1.336 |
| Cash At End Of Period
| 451.169 | 39.506 | 8.039 | 1.336 |